Synthesis and biological evaluation of fluorescent leishmanicidal analogues of hexadecylphosphocholine (miltefosine) as probes of antiparasite mechanisms

被引:21
作者
Saugar, Jose M.
Delgado, Javier
Hornillos, Valentin
Luque-Ortega, Juan R.
Amat-Guerri, Francisco
Acuna, A. Ulises
Rivas, Luis
机构
[1] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain
[2] CSIC, Inst Quim Organ, E-28006 Madrid, Spain
[3] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain
关键词
D O I
10.1021/jm070595+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The leishmanicidal mechanism of miltefosine (hexadecylphosphocholine, MT) is not clearly understood. Valuable insights into its mode of action could be obtained by fluorescence techniques, given suitably emitting analogues. In this regard, the synthesis and biological characterization of two fully competent NIT fluorescent analogues is reported here: all-(E)-13-phenyltrideca-6,8,10,12-tetraenylphosphocholine (PTE-MT) and all(E)-13-phenyltrideca-8,10,12-trien-6-ynylphosphocholine (PTRI-MT). Both compounds show large absorption coefficients and a,modest, but usable, fluorescence yield. Their activities were very similar to that of NIT and were recognized by the NIT uptake system of Leishmania. Their localization in living L. donovani promastigotes by confocal microscopy show a homogeneous intracellular distribution of the fluorescence. The concentration of PTRI-MT within the parasites (ca. 1.7 mM) showed a 100-fold enrichment relative to its external concentration. These results are consistent with a multiple target leishmanicidal mechanism for NIT and validate the application of these analogues for pharmacokinetic and diagnostic studies concerning the chemotherapy of leishmaniasis.
引用
收藏
页码:5994 / 6003
页数:10
相关论文
共 73 条
[11]   Chemotherapy of trypanosomiases and leishmaniasis [J].
Croft, SL ;
Barrett, MP ;
Urbina, JA .
TRENDS IN PARASITOLOGY, 2005, 21 (11) :508-512
[12]   Drug resistance in leishmaniasis [J].
Croft, SL ;
Sundar, S ;
Fairlamb, AH .
CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (01) :111-+
[13]   Chemotherapy of leishmaniasis [J].
Croft, SL ;
Yardley, V .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (04) :319-342
[14]   The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei [J].
Croft, SL ;
Snowdon, D ;
Yardley, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :1041-1047
[15]   Antiprotozoal activities of phospholipid analogues [J].
Croft, SL ;
Seifert, K ;
Duchêne, M .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2003, 126 (02) :165-172
[16]   THE ACTIVITY OF ALKYL PHOSPHORYLCHOLINES AND RELATED DERIVATIVES AGAINST LEISHMANIA-DONOVANI [J].
CROFT, SL ;
NEAL, RA ;
PENDERGAST, W ;
CHAN, JH .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (16) :2633-2636
[17]   Antiprotozoal lysophospholipid analogues: A comparison of their activity against trypanosomatid parasites and tumor cells [J].
de Castro, SL ;
Santa-Rita, RM ;
Urbina, JA ;
Croft, SL .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (02) :141-151
[18]   Leishmaniasis: current situation and new perspectives [J].
Desjeux, P .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2004, 27 (05) :305-318
[19]   Intracellular triggering of fas aggregation and recruitment of apoptotic molecules into fas-enriched rafts in selective tumor cell apoptosis [J].
Gajate, C ;
del Canto-Jañez, E ;
Acuña, AU ;
Amat-Guerri, F ;
Geijo, E ;
Santos-Beneit, AM ;
Veldman, RJ ;
Mollinedo, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :353-365
[20]   Review - The fluorescent toolbox for assessing protein location and function [J].
Giepmans, BNG ;
Adams, SR ;
Ellisman, MH ;
Tsien, RY .
SCIENCE, 2006, 312 (5771) :217-224